While we observed no statistical differences regarding TROP2 expression between right‐ and left‐sided cancers, we observed a slightly higher rate of TROP2 positivity in rectal cancers (p = 0.032, Figure 2C–G). The gene discussed is TACSTD2; the disease is rectal cancer.